Stay updated on Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.

Latest updates to the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.4.2 has been added to the study record history, and the v3.4.1 entry has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoChange DetectedThe history shows an added Revision: v3.4.1 and a removed Revision: v3.4.0, reflecting a small system update.SummaryDifference0.1%

- Check30 days agoChange DetectedUI updates include a Show glossary option, green additions and red deletions highlights, and a new Revision: v3.4.0 label, with No FEAR Act data and Revision: v3.3.4 removal. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check45 days agoChange DetectedThe Record History page adds a new revision entry v3.3.4 and removes the previous v3.3.3 entry. This is a log update and does not affect trial data or functionality.SummaryDifference0.1%

- Check66 days agoChange DetectedNew Revision: v3.3.3 appears on the page and the HHS Vulnerability Disclosure link is removed, indicating minor UI and footer updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check94 days agoChange DetectedThe record history now includes a new revision v3.3.2 and removes v3.2.0, reflecting a routine update to the study's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.